SHH:603811

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. · SHH · Healthcare · CNY · FY for 2025

Figures on this page computed 2026-11-08 13:42 UTC

Last close

n/aCNY

Market data

11.0xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
24.0%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
28.9%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
3.9%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed

Growth is the furthest below its sector's middle: 0.33 against 0.47 on the market's range.

All from 100

lens 2 of 9

Sales

253

2016-12-31 to 2025-12-31100 at the start253

Sales: 100.00 on 2016-12-31 to 252.89 on 2025-12-31, up 153%.

Profit

286

2016-12-31 to 2025-12-31100 at the start286

Profit: 100.00 on 2016-12-31 to 286.22 on 2025-12-31, up 186%.

Shares in issue

131

2016-12-31 to 2025-12-31100 at the start131

Shares in issue: 100.00 on 2016-12-31 to 130.68 on 2025-12-31, up 31%.

Sales is at 253, Profit is at 286, Shares in issue is at 131, against 100 in 2016.

Sales is at 253, Profit is at 286, Shares in issue is at 131, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100253
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Profit, where the first year is 100286
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Shares in issue, where the first year is 100131
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY